The past, present, and future of cancer incidence in the United States: 1975 through 2020

Cancer

Volumn 121, Issue 11, 2015, Pages 1827-1837

  Weir, Hannah K ^a   Thompson, Trevor D ^a   Soman, Ashwini ^b   Møller, Bjørn ^c   Leadbetter, Steven ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NORTHROP GRUMMAN CORPORATION   (United States)

^c CANCER REGISTRY OF NORWAY   (Norway)

Author keywords

cancer; cancer registries; incidence; predictions; projections; surveillance

Indexed keywords

AGE; ARTICLE; BLACK PERSON; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; EARLY DIAGNOSIS; ETHNICITY; FEMALE; GENDER; HIGH RISK POPULATION; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MALE; MELANOMA; POPULATION SIZE; PRIORITY JOURNAL; PROSTATE CANCER; THYROID CANCER; TREND STUDY; UTERUS CANCER; CANCER REGISTRY; INCIDENCE; NEOPLASMS; UNITED STATES;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 84929653253     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29258     Document Type: Article

References (47)

1. Edwards BK, Noone AM, Mariotto AB, et al., Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 2014; 120: 1290-1314.
2. US Cancer Statistics Working Group. United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Cancer Institute; 2013.
3. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; 2013. Available at: http://seer.cancer.gov/archive/csr/1975-2010/. Accessed January 16, 2015.
4. Vincent GK, Velkoff VA,. The Next Four Decades, The Older Population in the United States: 2010 to 2050. Current Population Reports P25-1138. Washington, DC: US Census Bureau; 2010.
5. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA,. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009; 27: 2758-2765.
6. Edwards BK, Howe HL, Ries LA, et al., Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002; 94: 2766-2792.
7. Nowatzki J, Moller B, Demers A,. Projection of future cancer incidence and new cancer cases in Manitoba, 2006-2025. Chronic Dis Can. 2011; 31: 71-78.
8. Mistry M, Parkin DM, Ahmad AS, Sasieni P,. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011; 105: 1795-1803.
9. Moller H, Fairley L, Coupland V, et al., The future burden of cancer in England: incidence and numbers of new patients in 2020. Br J Cancer. 2007; 96: 1484-1488.
10. Moller B, Fekjaer H, Hakulinen T, et al., Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev. 2002; 11 (suppl 1): S1-S96.
11. Bray F, Moller B,. Predicting the future burden of cancer. Nat Rev Cancer. 2006; 6: 63-74.
12. Hankey BF, Ries LA, Edwards BK,. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 1117-1121.
13. Parkin DM,. The role of cancer registries in cancer control. Int J Clin Oncol. 2008; 13: 102-111.
14. Lousdal ML, Kristiansen IS, Moller B, Stovring H,. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway. Eur J Public Health. 2014; 24: 1016-1021.
15. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute; 2012. Available at: http://seer.cancer.gov/archive/csr/1975-2009-pops09/index.html. Accessed January 16, 2015.
16. United States Census Bureau. 2008 National Population Projections: Downloadable Files [Internet]. Available at: census.gov/population/projections/data/national/2008/downloadablefiles.html. Accessed May 15, 2014.
17. Canadian Cancer Society. Canadian Cancer Statistics 1999. Toronto, Ontario, Canada: Canadian Cancer Society; 2014. http://www.cancer.ca/∼/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-1999-EN.pdf. Accessed January 16, 2015.
18. Moller B, Fekjaer H, Hakulinen T, et al., Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003; 22: 2751-2766.
19. National Center for Health Statistics, Centers for Disease Control and Prevention. Age Adjustment Using the 2000 Projected U.S. Population. Atlanta, GA: National Center for Health Statistics, Centers for Disease Control and Prevention; 2001. Available at: cdc.gov/nchs/data/statnt/statnt20.pdf. Accessed May 15, 2014.
20. Centers for Disease Control and Prevention (CDC). Decline in breast cancer incidence-United States, 1999-2003. MMWR Morb Mortal Wkly Rep. 2007; 56: 549-553.
21. Ravdin PM, Cronin KA, Howlader N, et al., The decrease in breast cancer incidence in 2003 in the United States. N Eng J Med. 2007; 356: 1670-1674.
22. Hankey BF, Feuer EJ, Clegg LX, et al., Cancer surveillance series: interpreting trends in prostate cancer-part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999; 91: 1017-1024.
23. DeSantis C, Howlader N, Cronin KA, Jemal A,. Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev. 2011; 20: 733-739.
24. Li J, Djenaba JA, Soman A, Rim SH, Master VA,. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007. Prostate Cancer. 2012; 2012: 691380.
25. Kochanek KD, Arias E, Anderson RN,. How did cause of death contribute to racial differences in life expectancy in the United States in 2010? NCHS Data Brief. 2013;(125): 1-8.
26. Kirby JB, Kaneda T,. "Double jeopardy" measure suggests blacks and Hispanics face more severe disparities than previously indicated. Health Aff (Millwood). 2013; 32: 1766-1772.
27. Olshansky SJ, Antonucci T, Berkman L, et al., Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood). 2012; 31: 1803-1813.
28. Centers for Disease Control and Prevention (CDC). Cancer survivors-United States 2007. MMWR Morb Mortal Wkly Rep. 2011; 60: 269-272.
29. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML,. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011; 103: 117-128.
30. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA,. Cancer treatment cost in the United States: has the burden shifted over time? Cancer. 2010; 116: 3477-3484.
31. Trogdon JG, Tangka FK, Ekwueme DU, Guy GP Jr, Nwaise I, Orenstein D,. State-level projections of cancer-related medical care costs: 2010 to 2020. Am J Manag Care. 2012; 18: 525-532.
32. Yang W, Williams JH, Hogan PF, et al., Projected supply of and demand for oncologists and radiation oncologists through 2025: an aging, better-insured population will result in shortage. J Oncol Pract. 2014; 10: 39-45.
33. Chapman SA, Mulvihill L, Herrera C,. Workload and time management in central cancer registries: baseline data and implication for registry staffing. J Registry Manag. 2012; 39: 178-184.
34. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
35. Jemal A, Thun MJ, Ries LA, et al., Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100: 1672-1694.
36. Jemal A, Travis WD, Tarone RE, Travis L, Devesa SS,. Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer. 2003; 105: 101-107.
37. Eheman C, Henley SJ, Ballard-Barbash R, et al., Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012; 118: 2338-2366.
38. Polednak AP,. Surveillance and interpretation of trends in US age-specific incidence rates for primary liver cancer, in relation to the epidemic of hepatitis C infection. J Registry Manag. 2013; 40: 115-121; quiz 144-145.
39. Jemal A, Simard EP, Dorell C, et al., Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105: 175-201.
40. Holman DM, Soman A, Watson M, Weir HK, Trivers KF, White MC,. Examination of the increase in thyroid cancer incidence among younger women in the United States by age, race, geography, and tumor size, 1999-2007. J Adolesc Young Adult Oncol. 2011;1: 95-102.
41. Morris LG, Sikora AG, Tosteson TD, Davies L,. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013; 23: 885-891.
42. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA,. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009; 129: 1666-1674.
43. Jemal A, Saraiya M, Patel P, et al., Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol. 2011; 65 (5 suppl 1): S17-S25.e1-e3.
44. Edwards BK, Ward E, Kohler BA, et al., Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
45. Moller B, Weedon-Fekjaer H, Hakulinen T, et al., The influence of mammographic screening on national trends in breast cancer incidence. Eur J Cancer Prev. 2005; 14: 117-128.
46. Merrill RM, Dearden KA,. How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States? Cancer Causes Control. 2004; 15: 1027-1034.
47. Wingo PA, Jamison PM, Hiatt RA, et al., Building the infrastructure for nationwide cancer surveillance and control-a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes Control. 2003; 14: 175-193.